India

Russian Scientists Develop Drug That Targets Antibiotic-Resistant Bacteria

 / Go to the mediabankEvaluation of Sputnik V Vaccine Effectiveness in the Gemotest Laboratory in Moscow, Russia / Go to the mediabank

Specialists at the Gamaleya Research Center for Epidemiology and Microbiology have developed an agent against antibiotic-resistant strains of Klebsiella pneumoniae.The drug works differently from conventional antibiotics by blocking the bacteria’s ability to produce toxins, move, invade cells, and form biofilms, rather than killing them outright.Klebsiella pneumoniae can cause severe pneumonia, bloodstream infections, and urinary tract infections, with fatality rates reaching 40% to 70%.In the EU, bloodstream infections caused by this bacterium rose 72% between 2019 and 2025, medical data shows.The development offers a way to counter resistance, since the danger comes not from the bacterium itself but from its strains that withstand standard treatment.RussiaFusion Power Within Reach by the 2050s, Says Russia’s Nuclear Chief 08:28 GMT

Source

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

seventeen − 14 =

Back to top button